Terms: = Bone cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671
1722 results:
1. International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update.
Rotz SJ; Bhatt NS; Hamilton BK; Duncan C; Aljurf M; Atsuta Y; Beebe K; Buchbinder D; Burkhard P; Carpenter PA; Chaudhri N; Elemuary M; Elsawy M; Guilcher GM; Hamad N; Karduss A; Peric Z; Purtill D; Rizzo D; Rodrigues M; Ostriz MBR; Salooja N; Schoemans H; Seber A; Sharma A; Srivastava A; Stewart SK; Baker KS; Majhail NS; Phelan R
Transplant Cell Ther; 2024 Apr; 30(4):349-385. PubMed ID: 38413247
[TBL] [Abstract] [Full Text] [Related]
2. Comparative Analysis of Skip Metastasis in Pediatric Osteosarcoma: Clinical Features and Outcomes.
Halalsheh H; Amer S; Omari Z; Shawagfeh M; Boheisi M; Sultan I
J Pediatr Hematol Oncol; 2024 Apr; 46(3):154-158. PubMed ID: 38408127
[TBL] [Abstract] [Full Text] [Related]
3. Natural history of bone-only metastasis in renal cell carcinoma.
Tang B; Duan R; Fan Z; Yan X; Li S; Zhou L; Li J; Xu H; Mao L; Lian B; Wang X; Bai X; Wei X; Li C; Cui C; Si L; Chi Z; Guo J; Sheng X
Urol Oncol; 2024 Apr; 42(4):119.e17-119.e22. PubMed ID: 38383241
[TBL] [Abstract] [Full Text] [Related]
4. Clinical and genetic characteristics predict outcomes of acute myeloid leukemia patients with FLT3 mutations receiving venetoclax-based therapy.
Weng G; Huang J; An N; Zhang Y; Yu G; Sun Z; Lin D; Deng L; Liang X; Xiao J; Zhang H; Guo Z; He X; Jin H; Liu Q; Du X
Cancer Med; 2024 Jan; 13(2):e6885. PubMed ID: 38334500
[TBL] [Abstract] [Full Text] [Related]
5. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
[TBL] [Abstract] [Full Text] [Related]
6. Clinical outcomes in patients with adamantinoma: Report from the bone and soft tissue tumor registry in Japan.
Shimizu J; Emori M; Murahashi Y; Kawai A; Teramoto A
J Surg Oncol; 2024 Apr; 129(5):1000-1005. PubMed ID: 38263585
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical pathological and genetic mutation characteristics of conjunctival lymphoepithelial carcinoma].
Wang YC; Li J; Guo YT; Li J; Lin JY
Zhonghua Yan Ke Za Zhi; 2024 Jan; 60(1):64-71. PubMed ID: 38199770
[No Abstract] [Full Text] [Related]
8. Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Nabergoj M; Eikema DJ; Koster L; Platzbecker U; Sockel K; Finke J; Kröger N; Forcade E; Nagler A; Eder M; Tischer J; Broers AEC; Kuball J; Wilson KMO; Hunault-Berger M; Collin M; Russo D; Corral LL; Helbig G; Mussetti A; Scheid C; Gurnari C; Raj K; Drozd-Sokolowska J; Yakoub-Agha I; Robin M; McLornan DP
Bone Marrow Transplant; 2024 Mar; 59(3):395-402. PubMed ID: 38195984
[TBL] [Abstract] [Full Text] [Related]
9. The role of insulinoma-associated protein 1 in predicting the progression and prognosis of human olfactory neuroblastoma in China.
Yang Y; Yue C; Li Y; Piao Y
Pathol Res Pract; 2024 Jan; 253():155040. PubMed ID: 38171083
[TBL] [Abstract] [Full Text] [Related]
10. Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma.
Shin JY; Offin M; Simone CB; Zhang Z; Shepherd AF; Wu AJ; Shaverdian N; Gelblum DY; Gomez DR; Sauter JL; Ginsberg MS; Adusumilli PS; Rusch VW; Zauderer MG; Rimner A
Radiother Oncol; 2024 Feb; 191():110057. PubMed ID: 38104783
[TBL] [Abstract] [Full Text] [Related]
11. Understanding differential technologies for detection of MRD and how to incorporate into clinical practice.
Cloos J; Ngai LL; Heuser M
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):682-690. PubMed ID: 38066915
[TBL] [Abstract] [Full Text] [Related]
12. Low bone Mineral Density and the Risk of Benign Paroxysmal Positional Vertigo.
Li J; Yu L; An P; Pang W; Yan X; Deng D; Song Y; Mao M; Qiu K; Rao Y; Cheng D; Zhang Y; Feng L; Wang X; Zhang Z; Zheng Y; Xu W; Ren J; Zhao Y
Otolaryngol Head Neck Surg; 2024 Mar; 170(3):877-885. PubMed ID: 38044484
[TBL] [Abstract] [Full Text] [Related]
13. Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With cancer in the United States.
Shen C; Thornton JD; Li N; Schaefer E; Zhou S; Kawasaki S; Pameijer C; Leslie D
Oncologist; 2024 Feb; 29(2):176-184. PubMed ID: 37944042
[TBL] [Abstract] [Full Text] [Related]
14. Disparities in Primary Spinal Osseous Malignant bone Tumor Survival by Medicaid Status: A National Population-Based Risk Analysis.
Ganga A; Kim EJ; Lee JY; Leary OP; Sastry RA; Fridley JS; Chang KE; Niu T; Sullivan PZ; Somasundar PS; Gokaslan ZL
World Neurosurg; 2024 Jan; 181():e192-e202. PubMed ID: 37777175
[TBL] [Abstract] [Full Text] [Related]
15. Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes.
Haque T; Cadenas FL; Xicoy B; Alfonso-Pierola A; Platzbecker U; Avivi I; Brunner AM; Chromik J; Morillo D; Patel MR; Falantes J; Leitch HA; Germing U; Preis M; Lenox L; Lauring J; Brown RJ; Kalota A; Mehta J; Pastore F; Gu J; Mistry P; Valcárcel D
Leuk Res; 2023 Nov; 134():107390. PubMed ID: 37776843
[TBL] [Abstract] [Full Text] [Related]
16. Computed Tomography Imaging Patterns of Sinonasal Inverted Papillomas: Comparison of Primary and Recurrent Disease.
Talati V; Holland K; Ansari SM; Filip P; Khalife S; Jhaveri MD; Tajudeen BA; Papagiannopoulos P; Batra PS
Laryngoscope; 2024 Apr; 134(4):1591-1596. PubMed ID: 37767874
[TBL] [Abstract] [Full Text] [Related]
17. Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation.
Emerging Risk Factors Collaboration
Lancet Diabetes Endocrinol; 2023 Oct; 11(10):731-742. PubMed ID: 37708900
[TBL] [Abstract] [Full Text] [Related]
18. AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts.
Zhao D; Zhou Q; Zarif M; Eladl E; Wei C; Atenafu EG; Schuh A; Tierens A; Yeung YWT; Minden MD; Chang H
Leuk Res; 2023 Nov; 134():107376. PubMed ID: 37690321
[TBL] [Abstract] [Full Text] [Related]
19. Progression before local control in osteosarcoma: Outcome and prognosis-predictive factors.
Halalsheh H; Amer S; Sultan I
Pediatr Blood Cancer; 2023 Nov; 70(11):e30649. PubMed ID: 37638816
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.
Hochman MJ; Othus M; Hasserjian RP; Ambinder A; Brunner A; Percival MM; Hourigan CS; Swords R; DeZern AE; Estey EH; Karp JE
Leukemia; 2023 Sep; 37(9):1915-1918. PubMed ID: 37524919
[TBL] [Abstract] [Full Text] [Related]
[Next]
